News and Comments

IDERA (IDRA): GOOD NEWS OFFSET SOMEWHAT BY SKEPTICISM NOT PESSIMISM

  Monday, March 04, 2013

Forgetting about Idera Pharmaceuticals (IDRA) seems to make its value sink, but failed to make it disappear. With a stock that sells at less than a three quarter of a dollar and a market of $20 million, lower than a new comer biotech having drugs still in preclinical lab testing, the firm was capable of drawing investors’ attention, riding new data about an attractive possibility of beating all existing approaches to treating psoriasis. The surprising data, which bring hopes in treating other autoimmune diseases, in addition to psoriasis were presented by James G. Krueger, M.D., PhD, of The Rockefeller University, at the Late-Breaking Research Symposium on March 2nd, 2013, during the American Academy of Dermatology Annual Meeting. More...


Recent Postings


Archive


Tags

Dynavax (DVAX) OSI (OSIP) Theravance (THRX) NEUROCRINE (NBIX) ZALTRAP™ CompuGen (CGEN) BIOMARIN (BMRN) Aimmune Therapeutics (AIMT) INNOVIVA (INVA) Jazz Pharmaceuticals (JAZZ) Ionis (IONS) Ziofpharm (ZIOP) Agenus (AGEN Incyte (INCY) Sanofi-Aventis (SAN) Revlimid (lenolidamide) PORTOLA (PTLA) KERYX (KERX) Epizyme (EPZM) Adaptimmune (ADAP) NOVOCURE (NVCR) AstraZeneca (AZN) Seattle Genetics (SGEN) Velcade (bortezomib) Prolor Biotech (PBTH) Sanofi (SNA) Zerenex Xoma (XOMA) ABBVIE (ABBV) Pluristem (PSTI) ARCA (ABIO) Inovio (INO) Rapamune AERIE PHARMACEUTICALS Akebia Therapeutics (AKAB) Gilead (GILD) Genentech SYNTA (SNTA) Onyx (ONXX) Illumina (ILMN) CRISPR Therapeutics (CRSP) C4 Therapeutics Sanofi (SNY) Mirati Therapeutics (MRTX) CEMPRA (CEMP) HALOZYME (HALO) ADVENTRIX (ANX) Theravance Bio Pharma (TBPH) VANDA (VNDA) JOUNCE THERAPEUTICS (JNCE) GlycoMimetics (GLYN) NEKTAR (NKTR)) Global Cell Therapeutics (GBT) Prosensa (RNA) Anadys (ANDS) Benlysta (belimumab) galapagos (GLPG) Vertex (VRTX) Galena (GALE) Tysabri Bellicum (BLCM) Valeant Pharmaceuticals International (VRX) Alnylam (ALNY) Telaprevir GlaxoSmithKline (GSK) Human Longevity (HLI) Human Genome Sciences (HGSI) REGULUS (RGLS) Roche (ROCHE) Trastuzumab-DM1 Spike Therapeutics (ONCE) Roche (RHHBY) Dendreon (DNDN) Intrexon (XON) Array Pharmaceuticals (ARRY) Cytokinetics (CYTK) Agenus (AGEN) KITE (KITE) Intercept (ICPT) Exelixis (EXEL) Anacor (ANAC) RenenxBio (RGNX) Micromet (MITI) Intermune (ITMN) Auspex (ASPX) ISIS (ISIS) Idenix (IDIX) AGOS (ARGS) JUNO (JUNO) Ridaforolimus Alder Biopharmaceuticals (ALDR) NANTKWEST (NK) Sequenom (SQNM) Elan (ELN) Multiple Myeloma Biocryst (BCRX) PTC Therapeutics (PTCT) Ocular Therapeutix (OCUL) TOKAI (TKAOI) Abbott Laboratories (ABT) LEXICON (LXRX) Regeneron (REGN) IDERA (IDRA) ACADIA (ACAD) OncoCyte (OCX) MODERNA Vitae Pharmaceuticals (VTAE) Ariad (ARIA) Endometrial Cancer Bristol-Myers Squibb (BMY) SERES THERAPEUTICS (MCRB) Herceptin GUARDIAN HEALTH Advaxis (ADXS) ARGOS (ARGS) Sangamo (SGMO) Amgen (AMGN) Editas (EDIT) SUNESIS PHARMACEUTICALS (SNSS) Sarepta (SRPT) Merck (MRK) Biogen Idec (BIIB) ImmunoGen (IMGN)